Assert-IQ vs Zio ECG Utilization Software (ZEUS) System
AI Verdict
Choose Assert-IQ if…
Choose Assert-IQ if your patient requires exceptionally long-term, continuous cardiac monitoring for potentially rare or intermittent arrhythmias that may not be captured by shorter-duration external monitors. This insertable cardiac monitor is ideal for diagnosing conditions like cryptogenic stroke or unexplained syncope where a prolonged monitoring period (up to 6 years) is necessary to detect elusive events.
View Assert-IQ →Choose Zio ECG Utilization Software (ZEUS) System if…
Choose the Zio ECG Utilization Software (ZEUS) System if you need a non-invasive, AI-powered solution for continuous ECG data analysis over a shorter diagnostic period, typically up to 14 days. This system is well-suited for patients experiencing more frequent symptomatic arrhythmias or for initial diagnostic workups where a wearable monitor and rapid, comprehensive end-of-wear reports are preferred for efficient clinical decision-making.
View Zio ECG Utilization Software (ZEUS) System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Assert-IQ | Zio ECG Utilization Software (ZEUS) System |
|---|---|---|
| Pricing | Enterprise | Unknown |
| Deployment | Hybrid | Cloud-based. |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio ECG Utilization Software (ZEUS) SystemTool B offers a more comprehensive and accessible user experience for clinicians with its dedicated ZioSuite web portal, mobile application for healthcare professionals, and HL7-based EHR integration. Tool A, while offering remote monitoring and a patient activator, lacks a stated clinician-facing mobile app or web portal and an API, which can limit its overall usability and integration into existing clinical workflows.
Clinical Value
Assert-IQAssert-IQ (Tool A) offers a significantly longer monitoring duration of up to 6 years via an insertable cardiac monitor, which is a substantial advantage for diagnosing infrequent or paroxysmal arrhythmias that might be missed by shorter-term monitoring solutions. While both utilize advanced AI, the extended monitoring period of Tool A provides greater potential for long-term diagnostic yield and patient management.
Pricing & Value
TieBoth tools operate on an enterprise pricing model with no publicly available pricing details or free trial options. Without transparent pricing information, it is impossible to conduct a meaningful head-to-head comparison on this dimension or determine which offers better value.
Enterprise Readiness
Zio ECG Utilization Software (ZEUS) SystemTool B demonstrates stronger enterprise readiness with its fully cloud-based deployment on AWS EC2 and explicit HL7-based EHR integration, which streamlines implementation and data flow within large healthcare systems. While Tool A is also FDA cleared and HIPAA compliant, its hybrid deployment and lack of an API may present more integration challenges for large enterprises.
Innovation
Assert-IQThe primary innovation of Assert-IQ (Tool A) lies in its ability to provide exceptionally long-term continuous cardiac monitoring for up to 6 years through an insertable cardiac monitor. This extended diagnostic window represents a significant advancement for detecting rare or intermittent arrhythmias compared to the 14-day monitoring period of Tool B's wearable solution.
Support & Docs
Zio ECG Utilization Software (ZEUS) SystemiRhythm (Tool B) offers a more comprehensive and readily available support ecosystem, including 24/7/365 provider support, a dedicated professional education platform (iRhythm Academy), and a specialized 24/7/365 billing team. While Abbott (Tool A) provides extensive documentation and technical support, iRhythm's explicit 24/7 availability across multiple support facets gives it an edge in responsiveness and accessibility for healthcare professionals.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Assert-IQ | Zio ECG Utilization Software (ZEUS) System |
|---|---|---|
| Name | Assert-IQ | Zio ECG Utilization Software (ZEUS) System |
| Company | Abbott Medical | iRhythm Technologies |
| Description | The Assert-IQu2122 Insertable Cardiac Monitor (ICM) system provides long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders. | The Zio ECG Utilization Software (ZEUS) System by iRhythm Technologies is an AI-powered, cloud-based platform that analyzes continuous ECG data from wearable Zio monitors to aid physicians in the diagnosis and management of cardiac arrhythmias. |
| Key Features | Long-term continuous cardiac monitoring (up to 6 years), Advanced arrhythmia detection algorithms, Bluetoothu00ae Low Energy data transmission, Secure cloud-based data platform, Remote monitoring capabilities, Proactive clinician alerts, Patient activator for symptom logging, Minimally invasive insertion | AI algorithm for arrhythmia detection and classification, Continuous ECG data analysis (up to 14 days), Cloud-based data analytics (AWS EC2 platform), Proprietary deep-learned algorithms for enhanced diagnostic accuracy, ZioSuite web portal and mobile application for healthcare professionals, Comprehensive end-of-wear reports for physician review, Integration with Zio wearable biosensors (Zio monitor, Zio Watch), HL7-based EHR integration |
| Categories | Cardiology AI, Clinical Decision Support & Reference | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Specialties | Cardiology, Internal Medicine | Cardiology, Family Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring Assert-IQ and Zio ECG Utilization Software (ZEUS) System.
Frequently Asked Questions
More Comparisons
More matchups featuring Assert-IQ or Zio ECG Utilization Software (ZEUS) System
Backers
Who funded each tool's parent company.